Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated liver disease.
Sogabe M, Okahisa T, Kagawa M, Kashihara T, Shinomiya R, Miyake T, Kawaguchi T, Yokoyama R, Kagemoto K, Kida Y, Okada Y, Tomonari T, Kawano Y, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: kagemoto k. Aliment Pharmacol Ther. 2024 Dec;60(11-12):1587-1598. doi: 10.1111/apt.18280. Epub 2024 Sep 23. Aliment Pharmacol Ther. 2024. PMID: 39310953
Association of variabilities in body mass index and waist circumference with newly achieved remission of metabolic dysfunction-associated fatty liver disease.
Sogabe M, Okahis T, Kagawa M, Sei M, Ueda H, Yokoyama R, Kagemoto K, Tanaka H, Kida Y, Nakamura F, Tomonari T, Okamoto K, Miyamoto H, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: kagemoto k. Diabetes Metab Syndr. 2024 May;18(5):103036. doi: 10.1016/j.dsx.2024.103036. Epub 2024 May 8. Diabetes Metab Syndr. 2024. PMID: 38754333
Impact of alcohol consumption on metabolic dysfunction-associated fatty liver disease development and remission: A longitudinal cohort study.
Sogabe M, Okahisa T, Kagawa M, Kashihara T, Fujmoto S, Kawaguchi T, Yokoyama R, Kagemoto K, Tanaka H, Kida Y, Tomonari T, Kawano Y, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: kagemoto k. Eur J Clin Invest. 2024 Sep;54(9):e14221. doi: 10.1111/eci.14221. Epub 2024 Apr 18. Eur J Clin Invest. 2024. PMID: 38634705
Association of metabolic dysfunction-associated steatotic liver disease with erosive esophagitis development: a longitudinal observational study.
Sogabe M, Okahisa T, Kagawa M, Sei M, Ueda H, Yokoyama R, Kagemoto K, Tanaka H, Kida Y, Nakamura F, Tomonari T, Okamoto K, Kawano Y, Miyamoto H, Sato Y, Nakasono M, Takayama T. Sogabe M, et al. Among authors: kagemoto k. J Gastroenterol Hepatol. 2024 Jun;39(6):1107-1114. doi: 10.1111/jgh.16530. Epub 2024 Feb 29. J Gastroenterol Hepatol. 2024. PMID: 38419514
Gastric fundic gland polyposis and cancer development after eradication of Helicobacter pylori in patient with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS).
Okamoto K, Kawaguchi T, Kagemoto K, Kida Y, Mitsui Y, Nakamura F, Yoshikawa K, Sogabe M, Sato Y, Shunto J, Bando Y, Shimada M, Takayama T. Okamoto K, et al. Among authors: kagemoto k. Gastric Cancer. 2024 May;27(3):635-640. doi: 10.1007/s10120-024-01473-x. Epub 2024 Feb 26. Gastric Cancer. 2024. PMID: 38407681
39 results